Wednesday, January 07, 2009 19:31 AEDT
ASX Announcements
Home
Investor information
ASX Announcements
About Us
Our mission
Our business
Symbion Health Careers
Contact us
Investor information
Shareholder centre
Financial reports and results
ASX Announcements
Search facility
News centre
Media releases
Corporate publications
Media resources
News search facility
Business units
Pathology
Diagnostic Imaging
Pharmacy Services
Medical Centres
Products & services
Pathology services
Diagnostic Imaging services
Pharmacy services
Medical Centres services
Contact us
Head office details
Shareholder centre
Financial reports and results
ASX Announcements
2007 ASX Announcements
2006 ASX Announcements
2005 announcements
Search facility
2005 announcements
Date
Title
23/12/2005
Demerger of Mayne Pharma - Communication with shareholders
20/12/2005
Appendix 3B.
19/12/2005
Appendix 3Y x 4
14/12/2005
Notification of Changes.
13/12/2005
Consumer site visit
13/12/2005
Pathology site visit
13/12/2005
MYP & SYB - CGT Cost Bases
07/12/2005
Form 604 Notice of change of interests of substantial holder
02/12/2005
Form 603 Notice of initial substantial holder
01/12/2005
Symbion Health acquires Mansfield Pathology
01/12/2005
Final Share Buy-Back Notice
30/11/2005
Form 604 Notice of change of interests of substantial holder
28/11/2005
Appendix 3Y - Change of Director's Interest Notice
28/11/2005
Appendix 3Y - Change of Director's Interest Notice
28/11/2005
Appendix 3X - Initial Director's Interest Notice
28/11/2005
Appendix 3B - new issue announcement
25/11/2005
Appendix 3Z
25/11/2005
Appendix 3B - new issue announcement
25/11/2005
Appendix 3Z
25/11/2005
Appendix 3Y- change in director's interest notice
25/11/2005
Appendix 3Z
25/11/2005
Appendix 3Z
25/11/2005
Appendix 3Z
21/11/2005
Introduction to Symbion Health
18/11/2005
Court approves Mayne demerger
16/11/2005
2005 EGM Presentation Slides
16/11/2005
2005 EGM Chairman's speech
16/11/2005
Demerger Scheme Meetings - Results of Meetings
15/11/2005
Appendix 3Y
14/11/2005
Appendix 3Y - change in director's interest notice
11/11/2005
Mayne prepares to defend NSW Payroll tax claim
10/11/2005
CEO Elect on Mayne Pharma
09/11/2005
Mayne welcomes continued certainty for community pharmacy
08/11/2005
AGM 2005 Chairmans address to shareholders
08/11/2005
AGM 2005 Group Managing Directors address to shareholders
08/11/2005
AGM 2005 Results of Meeting
08/11/2005
Mayne Group Limited Annual General Meeting 2005
03/11/2005
Mayne Receives US Court Judgement For Propofol
02/11/2005
Webcast of Annual General Meeting on 8 November 2005
18/10/2005
Appendix 3Y - change in director's interest notice
18/10/2005
Appendix 3Y - change in director's interest notice
14/10/2005
Appendix 3Y - change in director's interest notice
12/10/2005
Appendix 3Y - change in director's interest notice
10/10/2005
Proposed demerger of Mayne Pharma - Speech
10/10/2005
Explanatory Memorandum for Mayne Pharma Demerger
10/10/2005
Mayne releases Explanatory Memorandum for Shareholders
10/10/2005
Proposed demerger of Mayne Pharma Limited - presentation
07/10/2005
Annual Review 2005
07/10/2005
Financial Report 2005
07/10/2005
Notice of 2005 Annual General Meeting
05/10/2005
Appendix 3B - New issue announcement
03/10/2005
Appendix 3Y - Change of director's interest notice
23/09/2005
Mayne Lodges Explanatory Memorandum with ASIC and Proceeds With Proposed Demerger
12/09/2005
Annual Review and Full Financial Report 2005
12/09/2005
Annual Review 2005
12/09/2005
Financial Report 2005
12/09/2005
Appendix 3B - New issue announcement
06/09/2005
Dividend Reinvestment Plan - Share Price
31/08/2005
Mayne Pharma Announces New CEO Appointment
29/08/2005
Appendix 3B - New issue announcement
24/08/2005
Mayne reports healthy increase in full year EBIT
24/08/2005
Preliminary Final Report - Financial Year ended 30 June 2005
24/08/2005
2005 Full year results presentation
18/08/2005
Appendix 3Y - Change of Director's Interest Notice
17/08/2005
Mayne full year results webcast on 24 August 2005
09/08/2005
Mayne Announces Domestic Business CEO Appointment
05/08/2005
Mayne receives Australian court decision for Epirubicin
04/07/2005
Appendix 3X - Initial Director's Interest Notice
04/07/2005
Options expiring various dates & exercisable at various prices
01/07/2005
Mayne Pharma provides strategic update
28/06/2005
Mayne appoints non-executive director
17/06/2005
Update regarding proposed demerger
16/06/2005
Appendix 3X - Initial Director's Interest Notice (x 2)
08/06/2005
Mayne announces Board appointments
03/06/2005
Form 484 - Cancellation of shares
12/05/2005
Share buy-back
04/05/2005
Mayne to assess merits of demerger
18/04/2005
Paclitaxel update
06/04/2005
Options expiring various dates & exercisable at various prices
01/04/2005
Appendix 3Z - Final Director's Interest Notice
31/03/2005
Appendix 3Y - Change of Director's Interest Notice
31/03/2005
Appendix 3B - Dividend Reinvestment Plan
23/03/2005
Appendix 3F - Final Share Buy-Back Notice
23/03/2005
Form 484 - Cancellation of shares
21/03/2005
Retirement of Non-Executive Director
18/03/2005
Appendix 3Y - Change of Director's Interest Notice (x 6)
10/03/2005
Dividend Reinvestment Plan - Share Price
10/03/2005
Citigroup Annual Investment Conference presentation slides
09/03/2005
2005 ABN Amro Global Generic Pharmaceutical Conference.
08/03/2005
Appendix 3C - On Market Buy-Back Notice
25/02/2005
Mayne expands UK Aseptic Manufacturing Services
23/02/2005
Supplementary Information Pack for 6 months to 31 December 2004
23/02/2005
Half Year Report
23/02/2005
Half Year Results Presentation
23/02/2005
Mayne reports 26% increase in half year earnings
22/02/2005
Final Director's Interest Notice (x 2)
22/02/2005
Retirement of Mr Peter Barnett and Mr Peter Mason
22/02/2005
Mayne Pharma and Pliva enter biogeneric partnership
21/02/2005
Appointment of additional Company Secretary
18/02/2005
Mayne receives English Court of Appeal decision for Epirubicin
16/02/2005
Mayne half year results webcast on 23 February 2005
10/02/2005
Mayne receives USFDA warning letter on ADE reporting
02/02/2005
Mayne Pharma and Strides broaden supply and distribution partnership with anti-infective products
31/01/2005
Completion of Port Macquarie Base Hospital sale
14/01/2005
JP Morgan Healthcare Conference presentation slides
10/01/2005
JP Morgan Healthcare Conference presentation and webcast
Annual Report 2007
Download Annual Report
Quicklinks
News centre